{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:51:47Z","timestamp":1760986307935,"version":"3.44.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-05935-8","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T07:28:26Z","timestamp":1753860506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of demographic characteristics and haematological parameters in newborns with and without haemolytic disease due to ABO incompatibility"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0443-2148","authenticated-orcid":false,"given":"Kamil","family":"Sahin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-6398","authenticated-orcid":false,"given":"Tahir","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9794-9460","authenticated-orcid":false,"given":"Demet Deniz","family":"Bilgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7172-0812","authenticated-orcid":false,"given":"Derya","family":"B\u00fcy\u00fckkayhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0510-965X","authenticated-orcid":false,"given":"Murat","family":"Elevli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"5935_CR1","unstructured":"Firouzi M, Yazdanmehr R, Eliasy H, Birjandi M, Goudarzi A, Almasian M et al. The prevalence of the ABO hemolytic disease of the newborn and its complications in an Iranian population. Iran J Ped Hematol Oncol. 2018; 8(1):37\u201347. http:\/\/ijpho.ssu.ac.ir\/article-1-311-en.html."},{"key":"5935_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1182\/asheducation-2015.1.146","volume":"2015","author":"M Delaney","year":"2015","unstructured":"Delaney M, Matthews DC. Hemolytic disease of the fetus and newborn managing the mother, fetus, and newborn. Hematology Am Soc Hematol Educ Program. 2015;2015:146\u201351.","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"5935_CR3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s41372-021-00963-5","volume":"41","author":"J Pan","year":"2021","unstructured":"Pan J, Zhan C, Yuan T, Chen X, Ni Y, Shen Y, et al. Intravenous immunoglobulin G in the treatment of ABO hemolytic disease of the newborn during the early neonatal period at a tertiary academic hospital: a retrospective study. J Perinatol. 2021;41:1397\u2013402. https:\/\/doi.org\/10.1038\/s41372-021-00963-5.","journal-title":"J Perinatol"},{"key":"5935_CR4","doi-asserted-by":"publisher","unstructured":"Fisk JM, Pisciotto PT, Snyder EL, Peter L, Perrotta. Blood Banking and Transfusion Medicine (Second Edition), Churchill Livingstone, 2007, Chap. 23 - Platelets and Related Products, Editor(s): Christopher D. Hillyer, Leslie E. Silberstein, Paul M. Ness, Kenneth C. Anderson, John D. Roback, Pages 308\u2013341, ISBN 9780443069819. https:\/\/doi.org\/10.1016\/B978-0-443-06981-9.50028-4. https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780443069819500284.","DOI":"10.1016\/B978-0-443-06981-9.50028-4"},{"key":"5935_CR5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1182\/blood.V95.2.528","volume":"95","author":"T Gainsford","year":"2000","unstructured":"Gainsford T, Nandurkar H, Metcalf D, Robb L, Begley CG, Alexander WS. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor. Blood. 2000;95:528\u201334.","journal-title":"Blood"},{"key":"5935_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.exphem.2020.07.006","volume":"88","author":"S Hacein-Bey-Abina","year":"2020","unstructured":"Hacein-Bey-Abina S, Estienne M, Bessoles S, Echchakir H, Pederzoli-Ribeil M, Chiron A, Aldaz-Carroll L, Leducq V, Zhang Y, Souyri M, Louache F, Abina AM. Erythropoietin is a major regulator of thrombopoiesis in thrombopoietin-dependent and -independent contexts. Exp Hematol. 2020;88:15\u201327. Epub 2020 Jul 25. PMID: 32721504.","journal-title":"Exp Hematol"},{"issue":"3","key":"5935_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.26650\/jchild.2022.1130184","volume":"22","author":"B Yasa","year":"2022","unstructured":"Yasa B, Uslu SI, Memur S, Yavuzcan Ozturk D, Bagci O, Can Buker HS, Aksoy M, et al. ABO hemolitik Hastal\u0131\u011f\u0131 Olan Yenido\u011fan bebeklerde intraven\u00f6z Immunglobulin G (IVIG) Kullan\u0131m\u0131n\u0131n klinik sonu\u00e7lar \u00dczerine Etkisi. \u00c7ocuk Dergisi - J Child. 2022;22(3):172\u20137. https:\/\/doi.org\/10.26650\/jchild.2022.1130184.","journal-title":"\u00c7ocuk Dergisi - J Child"},{"issue":"10","key":"5935_CR8","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/pbc.25543","volume":"62","author":"M Valente","year":"2015","unstructured":"Valente M, Cortesi PA, Lassandro G, Mathew P, Pocoski J, Molinari AC, Mantovani LG, Giordano P. Health economic models in hemophilia A and utility assumptions from a clinician\u2019s perspective. Pediatr Blood Cancer. 2015;62(10):1826\u201331. https:\/\/doi.org\/10.1002\/pbc.25543.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"5935_CR9","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1097\/AOG.0000000000002528","volume":"131","author":"ACOG Practice Bulletin No","year":"2018","unstructured":"ACOG Practice Bulletin No. 192: management of alloimmunization during pregnancy. Obstet Gynecol. 2018;131(3):e82\u201390.","journal-title":"Obstet Gynecol"},{"key":"5935_CR10","doi-asserted-by":"crossref","unstructured":"Practice Bulletin No. 181: Prevention of Rh D Alloimmunization. Obstet Gynecol. 2017;130(2):e57-e70.","DOI":"10.1097\/AOG.0000000000002232"},{"issue":"2","key":"5935_CR11","doi-asserted-by":"publisher","first-page":"F83","DOI":"10.1136\/adc.2005.076794","volume":"92","author":"NA Murray","year":"2007","unstructured":"Murray NA, Roberts IA. Haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed. 2007;92(2):F83\u20138.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"11","key":"5935_CR12","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s41372-023-01650-3","volume":"43","author":"JM Gabbay","year":"2023","unstructured":"Gabbay JM, Agneta EM, Turkington S, Bajaj BM, Sinha B, Geha T. Rates of phototherapy among ABO-incompatible newborns with a negative direct antiglobulin test. J Perinatol. 2023;43(11):1357\u201362.","journal-title":"J Perinatol"},{"issue":"8","key":"5935_CR13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/MPH.0000000000001248","volume":"41","author":"RA Metcalf","year":"2019","unstructured":"Metcalf RA, Khan J, Andrews J, Mayock D, Billimoria Z, Pagano MB. Severe ABO hemolytic disease of the newborn requiring exchange transfusion. J Pediatr Hematol Oncol. 2019;41(8):632\u20134.","journal-title":"J Pediatr Hematol Oncol"},{"key":"5935_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2147\/PHMT.S327032","volume":"12","author":"AK Myle","year":"2021","unstructured":"Myle AK, Al-Khattabi GH. Hemolytic disease of the newborn: A review of current trends and prospects. Pediatr Health Med Ther. 2021;12:491\u20138.","journal-title":"Pediatr Health Med Ther"},{"issue":"3","key":"5935_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/tme.12512","volume":"29","author":"A Matteocci","year":"2019","unstructured":"Matteocci A, De Rosa A, Buffone E, Pierelli L. Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years. Transfus Med. 2019;29(3):197\u2013201. https:\/\/doi.org\/10.1111\/tme.12512.","journal-title":"Transfus Med"},{"issue":"2","key":"5935_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1179\/2046905512Y.0000000002","volume":"32","author":"YR Bhat","year":"2012","unstructured":"Bhat YR, Pavan Kumar CG. Morbidity of ABO haemolytic disease in the newborn. Paediatrics Int Child Health. 2012;32(2):93\u20136. https:\/\/doi.org\/10.1179\/2046905512Y.0000000002.","journal-title":"Paediatrics Int Child Health"},{"issue":"12","key":"5935_CR17","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1055\/s-0040-1722328","volume":"39","author":"M T\u0131ra\u015f","year":"2022","unstructured":"T\u0131ra\u015f M, Can E, Hamil\u00e7\u0131kan \u015e. Role of cord blood carboxyhemoglobin in detecting significant hyperbilirubinemia in term neonates with ABO alloimmunization. Am J Perinatol. 2022;39(12):1321\u20135. https:\/\/doi.org\/10.1055\/s-0040-1722328.","journal-title":"Am J Perinatol"},{"issue":"2","key":"5935_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.pedneo.2012.01.012","volume":"53","author":"S-H Chen","year":"2012","unstructured":"Chen S-H, Lin M, Yang K-L, Lin T-Y, Tsai H-H, Yang S-H, et al. Association of ABO incompatibility with red blood cell indices of cord blood unit. Pediatr Neonatol. 2012;53(2):138\u201343. https:\/\/doi.org\/10.1016\/j.pedneo.2012.01.012.","journal-title":"Pediatr Neonatol"},{"key":"5935_CR19","unstructured":"Dean L, Biotechnology Information (US). Blood Groups and Red Cell Antigens [Internet]. Bethesda (MD): National Center for; 2005. Chapter 5, The ABO blood group. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK2267\/."}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05935-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05935-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05935-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T07:39:45Z","timestamp":1757317185000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05935-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5935"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05935-8","relation":{},"ISSN":["1471-2431"],"issn-type":[{"type":"electronic","value":"1471-2431"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For our retrospective cross sectional study, ethics committee approval was obtained from the Haseki Education and Research Hospital Clinical Research Ethics Committee on December 6, 2023, with the approval number 233\/2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent could not be obtained for our retrospective study. Data were anonymized. This was also declared to the ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"582"}}